Vetoquinol SA (LON: 0O1O)
London
· Delayed Price · Currency is GBP · Price in EUR
65.20
-0.40 (-0.61%)
Jan 23, 2025, 9:12 AM BST
Vetoquinol Revenue
Vetoquinol had revenue of 264.44M EUR in the half year ending June 30, 2024, a decrease of -2.34%. This brings the company's revenue in the last twelve months to 537.47M, up 2.32% year-over-year. In the year 2023, Vetoquinol had annual revenue of 529.27M, down -1.95%.
Revenue (ttm)
537.47M EUR
Revenue Growth
+2.32%
P/S Ratio
n/a
Revenue / Employee
220.27K EUR
Employees
2,440
Market Cap
655.44M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 529.27M | -10.51M | -1.95% |
Dec 31, 2022 | 539.78M | 18.51M | 3.55% |
Dec 31, 2021 | 521.27M | 93.81M | 21.94% |
Dec 31, 2020 | 427.47M | 31.48M | 7.95% |
Dec 31, 2019 | 395.99M | 28.05M | 7.62% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |